A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin

NCT02995720 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension, Hyperlipidemia

Interventions

DRUG: Fimasartan/Amlodipine combination drug, Rosuvastatin

Sponsor

Boryung Pharmaceutical Co., Ltd